EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 21 filers reported holding EFFECTOR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $268,481 | +10.8% | 574,413 | +42.2% | 0.00% | – |
| Q3 2023 | $242,375 | -28.1% | 404,026 | -0.5% | 0.00% | – |
| Q2 2023 | $336,994 | +135.4% | 405,919 | 0.0% | 0.00% | – |
| Q1 2023 | $143,168 | -22.0% | 405,919 | -5.4% | 0.00% | – |
| Q4 2022 | $183,459 | -25.1% | 429,043 | 0.0% | 0.00% | – |
| Q3 2022 | $245,000 | -66.6% | 429,043 | -17.0% | 0.00% | – |
| Q2 2022 | $734,000 | -64.6% | 516,798 | 0.0% | 0.00% | – |
| Q1 2022 | $2,072,000 | -51.5% | 516,798 | +0.1% | 0.00% | – |
| Q4 2021 | $4,274,000 | – | 516,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,822,114 | $27,357,000 | 14.00% |
| Abingworth LLP | 4,822,114 | $18,903,000 | 5.36% |
| Column Group LLC | 4,309,329 | $17,280,000 | 3.20% |
| OUP Management Co., LLC | 1,025,697 | $4,113,000 | 3.13% |
| SECTORAL ASSET MANAGEMENT INC | 2,382,744 | $9,555,000 | 1.70% |
| Parallel Advisors, LLC | 677,452 | $2,744,000 | 0.11% |
| Oasis Management Co Ltd. | 100,000 | $401,000 | 0.06% |
| Blackstone Inc. | 1,308,587 | $5,248,000 | 0.01% |
| ALPS ADVISORS INC | 46,537 | $187,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 548 | $2,000 | 0.00% |